Pulli Chemical Industry

Hainan Puli Pharmaceutical is a prominent Chinese pharmaceutical enterprise specializing in the research, development, and international commercialization of high-end generic medications and contrast agents. Established in 1992, the company has achieved significant success in global markets, with a robust portfolio of products approved by the US FDA, EMA, and WHO. Their expertise lies in complex formulations and injectable drugs, covering therapeutic areas such as anti-infectives, cardiovascular health, and diagnostic imaging. Puli operates multiple manufacturing sites that comply with international GMP standards, providing high-quality pharmaceutical products and contract development and manufacturing services (CDMO) to a global clientele. The company is recognized for its commitment to quality and its role as a key supplier in the global pharmaceutical supply chain. With a strong emphasis on R&D, Puli continues to expand its pipeline into complex generics and innovative formulations.